EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
2.3.1.17 | Adenocarcinoma |
26511490 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. |
causal interaction diagnostic usage unassigned |
3 4 0 |
2.3.1.17 | Alzheimer Disease |
25766789 |
Transcriptional regulation of N-acetylaspartate metabolism in the 5xFAD model of Alzheimer's disease: Evidence for neuron-glia communication during energetic crisis. |
therapeutic application unassigned |
1 0 |
2.3.1.17 | Canavan Disease |
28007430 |
Design and optimization of aspartate N-acetyltransferase inhibitors for the potential treatment of Canavan disease. |
causal interaction therapeutic application unassigned |
3 4 0 |
2.3.1.17 | Canavan Disease |
29456021 |
Brain Nat8l Knockdown Suppresses Spongiform Leukodystrophy in an Aspartoacylase-Deficient Canavan Disease Mouse Model. |
ongoing research therapeutic application unassigned |
1 1 0 |
2.3.1.17 | Canavan Disease |
32787146 |
Discovery of Novel Inhibitors of a Critical Brain Enzyme Using a Homology Model and a Deep Convolutional Neural Network. |
therapeutic application unassigned |
4 0 |
2.3.1.17 | Canavan Disease |
34477360 |
High Throughput Screening Cascade To Identify Human Aspartate N-Acetyltransferase (ANAT) Inhibitors for Canavan Disease. |
diagnostic usage unassigned |
1 0 |
2.3.1.17 | Carcinoma |
26511490 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. |
causal interaction diagnostic usage unassigned |
3 4 0 |
2.3.1.17 | Carcinoma, Non-Small-Cell Lung |
26511490 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. |
causal interaction diagnostic usage unassigned |
3 4 0 |
2.3.1.17 | Carcinoma, Non-Small-Cell Lung |
31488434 |
Correction: Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. |
causal interaction unassigned |
1 0 |
2.3.1.17 | Carcinoma, Squamous Cell |
26511490 |
Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non-Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. |
causal interaction diagnostic usage unassigned |
3 4 0 |